Evidence map›Paper›PMID 27663638›Full record

ReviewEuropean journal of radiology2017

PET imaging approaches for inflammatory lung diseases: Current concepts and future directions.

Delphine L Chen, Mark L Schiebler, Jin Mo Goo, Edwin J R van Beek

Abstract readReview
In one paragraph

Review in European journal of radiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Open question: CanJournal of medical microbiology · 2026
    Article
  2. Review
  3. Article
  4. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  5. Frontiers in medicine · 2024
    Article
  6. Article
  7. High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  8. Utilizing MRI, [Frontiers in nuclear medicine · 2023
    Article
  9. Non-invasive molecular imaging of kidney diseases.Nature reviews. Nephrology · 2021
    Review
  10. The lungs were on fire: a pilot study ofArthritis research & therapy · 2021
    Article
  11. Inflammatory response in lungs and extrapulmonary sites detected by [European journal of nuclear medicine and molecular imaging · 2021
    Article
  12. Review
  13. Arthritis research & therapy · 2021
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Fibrosis imaging: Current concepts and future directions.Advanced drug delivery reviews · 2017
    Review
  19. Quantification of Lung PET Images: Challenges and Opportunities.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2017
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Delphine L ChenDivisions of Radiological Sciences and Nuclear Medicine, Mallinckrodt Institute of Radiology, Campus Box 8225, 510S, Kingshighway Blvd, St. Louis, MO, USA. Electronic address: chend@wustl.edu.
Mark L SchieblerDepartment of Radiology, UW-Madison School of Medicine and Public Heath, Madison, WI, USA.
Jin Mo GooDepartment of Radiology, Seoul National University, Seoul, Korea.
Edwin J R van BeekClinical Research Imaging Centre, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.

Funding

POSITRON EMISSION TOMOGRAPHIC IMAGING OF LUNG TRANSPLANTR01HL121218 · NHLBI · WASHINGTON UNIVERSITY · PI CHEN, DELPHINE L, GELMAN, ANDREW ERIC · 2014 to 2017
$2.8M
NHLBI NIH HHS R01 HL121218
6 · The paper itself

Abstract

Inflammatory lung disease is one of the most common clinical scenarios, and yet, it is often poorly understood. Inflammatory lung disorders, such as chronic obstructive pulmonary diseases, which are causing significant mortality and morbidity, have limited therapeutic options. Recently, new treatments have become available for pulmonary fibrosis. This review article will describe the new insights that are starting to be gained from positron emission tomography (PET) methods, by targeting molecular processes using dedicated radiotracers. Ultimately, this should aid in deriving better pathophysiological classification of these disorders, which will ultimately result in better evaluation of novel therapies.

Indexed as

AsthmaFluorodeoxyglucose F18HumansPeptidesPneumoniaPolyethylene GlycolsPositron-Emission TomographyPulmonary Disease, Chronic ObstructivePulmonary FibrosisRadiopharmaceuticalsAH 111585Fluorodeoxyglucose F18PeptidesPolyethylene GlycolsRadiopharmaceuticals(18)Fluorodeoxyglucose(18)Fluoro-fluciclatide(18)F-NOSAsthmaCOPDPositron emission tomographyPulmonary fibrosis

Identifiers

PMID27663638
PMCPMC13198165

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.